Background Upper tract urothelial carcinoma (UTUC) is a rare and heterogeneous disease.
Several clinical and biological prognostic factors have been identified in multi-institutional …

CONTEXT: The heterogeneity of upper tract urothelial carcinoma (UTUC) biology and
prognosis, as well as the presence of different treatment options, makes the clinical decision …

Introduction Tumor stage and grade represent the best established predictors for the
prognosis of upper tract urothelial carcinoma (UTUC). However, controversies still exist …

Objective UTUCC is a rare tumor, and most reports on prognostic factors come from small
single-center series. The objective of this article was to provide an updated overview of …

Purpose Upper-tract urothelial carcinoma (UTUC) is a relatively uncommon disease with
limited available evidence on specific topics. The purpose of this article was to review the …

Background Upper tract urothelial carcinoma (UTUC) accounts for< 5% of all urothelial
cancers. Although the main treatment is radical nephroureterectomy (NU), oncologic …

Simple Summary To choose the appropriate treatment for patients with upper tract urothelial
carcinoma (UTUC), proper diagnosis and risk assessment of the disease is mandatory. This …

Upper tract urothelial carcinomas (UTUCs) consist of 5%–10% of all urothelial carcinomas,
the rest being urothelial carcinomas of the bladder (UCB). There is increasing evidence to …

Urothelial carcinomas (UC) arise from the urothelium that covers the proximal urethra,
urinary bladder, and the upper urinary tract. In daily routine and clinical trials UC originating …

CONTEXT: The European Association of Urology (EAU) guideline group for upper tract
urothelial carcinoma (UTUC) has prepared updated guidelines to aid clinicians in assessing …